Cargando…
CD73 downregulation by EGFR-targeted liposomal CD73 siRNA potentiates antitumor effect of liposomal doxorubicin in 4T1 tumor-bearing mice
Blocking CD73 ectonucleotidase has been proposed as a potential therapeutic approach for cancer treatment. The present study aimed to investigate the antitumor effect of a novel EGFR-Targeted liposomal CD73 siRNA formulation in combination therapy with liposomal doxorubicin in the 4T1 mouse model. C...
Autores principales: | Soleimani, Anvar, Mirzavi, Farshad, Nikoofal-Sahlabadi, Sara, Nikpoor, Amin Reza, Taghizadeh, Bita, Barati, Mehdi, Soukhtanloo, Mohammad, Jaafari, Mahmoud Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213518/ https://www.ncbi.nlm.nih.gov/pubmed/35729230 http://dx.doi.org/10.1038/s41598-022-14392-7 |
Ejemplares similares
-
Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy
por: Askarizadeh, Anis, et al.
Publicado: (2023) -
Targeting the tumor microenvironment by liposomal Epacadostat in combination with liposomal gp100 vaccine
por: Tahaghoghi-Hajghorbani, Sahar, et al.
Publicado: (2023) -
Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma
por: Nik, Maryam Ebrahimi, et al.
Publicado: (2019) -
The Roles of CD73 in Cancer
por: Gao, Zhao-wei, et al.
Publicado: (2014) -
Author Correction: Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma
por: Nik, Maryam Ebrahimi, et al.
Publicado: (2020)